We identified a trend toward increased prevalence and levels of AT1R-Ab in all COVID-19 cases versus controls, as well as significantly higher median AT1R-Ab levels amongst individuals with mild COVID-19 versus their matched controls. Here, AGTR1 is linked to COVID-19.